Green Synthesis of Mentha spicata L.-derived Silver Nanoparticles: Evaluation of Antioxidant, Antibacterial, and Anticancer Potential against Triple-Negative Breast Cancer Cells [0.03%]
以薄荷为原料的银纳米颗粒的绿色合成及其抗氧化、抗菌及抗三阴性乳腺癌细胞增殖活性评价研究
Abdulrahman Abdullateef,Immaculata Amarachi Unegbu,Emmanuel Mshelia Halilu
Abdulrahman Abdullateef
Introduction: Mentha spicata L. (Lamiaceae) has been used in traditional medicine to cure indigestion, stomach aches, and diarrhea. This research aims to synthesize silver nanoparticles from aqueous extract of M. spicata ...
A Needle in a Haystack: The Precision of Liquid Biopsy in Finding Bone Tumors [0.03%]
大海捞针——液体活检技术在骨肿瘤中的精准应用
Anthony Nohra,Guy Awad,John Victor El Khoury et al.
Anthony Nohra et al.
Introduction: Bone tumors, especially in advanced stages, pose serious diagnostic and therapeutic challenges due to their aggressive nature and the invasiveness of traditional biopsy techniques. Liquid biopsy offers a pro...
An Updated Insight into the Phytomolecules Reported for the Treatment of Colon Cancer from 2015 to 2024 [0.03%]
2015至2024年用于结肠癌治疗的植物分子研究进展综述
Zulfa Nooreen,Awani Kumar Rai,Poonam Jaisal et al.
Zulfa Nooreen et al.
Introduction: During the last 20 years, the prevalence of colon cancer, among the most prevalent gastrointestinal cancers globally, has increased in the majority of nations. The current review compiled phytochemicals repo...
Design, Synthesis, Bioactivity, and Docking Studies of Isatin-Hydrazone Derivatives as Potential CDK-2 Inhibitors [0.03%]
作为潜在的CDK-2抑制剂的设计、合成、生物活性和对接研究的异羟肟酸衍生物
Ye Tao,Kaige Guo,Xiaofen Liao et al.
Ye Tao et al.
Introduction: Isatin derivatives are an important class of nitrogen-containing heterocyclic compounds that have exhibited a broad spectrum of pharmacological and biological activities. The condensation reaction of isatin ...
Traditional and Sustainable Methods for the Synthesis of Quinoline Derivatives as Anticancer Agents (2019-Present): A Comprehensive Review [0.03%]
用于抗癌的喹啉衍生物的传统及可持续合成方法(2019-至今)：综述性研究
Gajendra S Thakur,Ajay K Gupta,Yogesh Vaishnav et al.
Gajendra S Thakur et al.
Introduction: Heterocyclic compounds are widely utilized in the development of anticancer medications due to their diverse structures and ability to interact with multiple biological targets within cancer cells. Quinoline...
Disrupting Cancer Pathways with Nanogel-Encapsulated Wheatgrass Phytopharmaceuticals for Skin Cancer Therapy [0.03%]
用于皮肤癌治疗的纳米凝胶包被的小麦草植物药干预癌症途径
Devendra Singh,Atul Pratap Singh,Ramji Gupta
Devendra Singh
Introduction: Skin cancer is a major global health concern, with rising prevalence and limited effectiveness of conventional therapies. Natural phytopharmaceuticals, particularly those derived from Triticum aestivum (whea...
Irena Kostova
Irena Kostova
The article entitled "Titanium and vanadium complexes as anticancer agents", by Kostova I., has been retracted. Kindly see Bentham Science Policy on Article retraction at the link given below: (https://benthamscience.com/journals/anti-cance...
Network Pharmacology Reveals Luteolin From Vitex Negundo Novel Targets CDK1/Cyclin B In ER+ Breast Cancer Stem Cells [0.03%]
网络药理学揭示了乳香草素从假荆芥在ER+乳腺癌干细胞中新的作用靶点CDK1/Cyclin B
Rajesh Basnet,Buddha Bahadur Basnet,Sun Zhaojian et al.
Rajesh Basnet et al.
Introduction: Breast cancer remains a leading cause of cancer-related mortality in women, primarily due to Breast Cancer Stem Cells (BCSCs), which contribute to tumor progression, metastasis, and resistance to conventiona...
Discovery of Small Molecule Inhibitors against Polo-Like Kinase 1 Targeting Breast Cancer [0.03%]
靶向乳腺癌的Plk1小分子抑制剂的发现
Gayatri Munieswaran,Venkatraman Manickam
Gayatri Munieswaran
Introduction: The polo-like kinase-1 (PLK1) plays a significant role in cell cycle regulation and proliferation; upon dysregulation, PLK1 activates different oncogenic pathways that lead to breast cancer. Therefore, targe...
Molecular Simulation, Pharmacophore Mapping, and 3D QSAR Modeling on Chromene-Based SERDs [0.03%]
基于分子模拟、药效团映射和三维定量结构活性关系的色烯类SERD研究
Suresh Thareja,Sanjana Bisht
Suresh Thareja
Introduction: Estrogen receptor (ERα) is known to be a legitimate therapeutic target for the treatment of ER-positive breast cancer. Although selective estrogen receptor degraders (SERDs) like fulvestrant suppress ER sig...